. 2021 Aug 20;12(4):1542–1566. doi: 10.1016/j.apsb.2021.08.017
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 6.
EV-A71 2B inhibitor.